Audrain Medical Center announced that is successfully conducted its first MRI scan on a patient with the Revo MRITM SureScan® pacing system.
The Revo MRITM SureScan® pacemaker is the first MR-Conditional pacemaker system to be designed, tested and FDA approved for use in the MRI environment. (MR-Conditional is a term used to indicate that a device may be used in an MRI environment under certain conditions, such as certain type of MRI scanner or scanner settings.)
Prior to the Revo MRI Sure Scan® pacing system, MRI procedures for patients with implanted pacemakers were not recommended because the patients might face serious complications during the scan due to interference with pacemaker operation, damage to system components, lead or pacemaker dislodgement.
Developed by Medtronic, the Revo MRI SureScan® pacing system is the first pacing system of its kind in the U.S. The system was designed to address safety concerns around MRI procedures for patients who have implanted pacemakers. MRI scanners may cause traditional pacemakers to misinterpret MRI-generated electrical noise and withhold pacing therapy or deliver unnecessary pacing therapy. The Revo MRI pacing system, when programmed into SureScan mode prior to an MRI scan, is designed to be used safely in the MRI environment.
“Before this advanced technology became available, patients who needed regular MRI scans would either have to live without a pacemaker or suffer the possible consequences, or they would only be able to have a CT scan, which can be less accurate than a MRI when looking at a mass, for example, “ stated Larry Handlin, DO, Cardiologist.
“MRI scans are used to diagnose an array of medical conditions; therefore, this pacemaker is a significant advancement in that it no longer limits patients to the testing they can have done. This is the biggest advancement for this type of technology since the pacemaker was originally invented.”